NCT04225390 2026-02-10
PROMIT
University of Erlangen-Nürnberg Medical School
Phase 2 Completed
Clinical Trials
9 trialsNCT07191405 2025-09-24
Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT07155811 2025-09-04
T-ECHNICO
Centre Leon Berard
Phase NA Not yet recruiting
NCT06946745 2025-04-27
Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Recruiting
NCT06276088 2024-03-15
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
Nanfang Hospital, Southern Medical University
Recruiting
NCT04169841 2024-02-13
GUIDE2REPAIR
Centre Georges Francois Leclerc
Phase 2 Active not recruiting
NCT05719324 2023-02-10
Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05354375 2022-04-29
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Recruiting
NCT04587817 2020-10-14
Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors
Peking University First Hospital
Unknown